1. RangelCB.H.R.3590 ‐ 111th Congress (2009–2010): Patient Protection and Affordable Care Act;2010. Accessed June 8 2022https://www.congress.gov/bill/111th-congress/house-bill/3590
2. Center for Drug Evaluation and Research. Considerations in Demonstrating Interchangeability With a Reference Product Guidance for Industry;2020. Accessed June 8 2022.https://www.fda.gov/regulatory-information/search-fda-guidance-documents/considerations-demonstrating-interchangeability-reference-product-guidance-industry.
3. European Medicines Agency European Commission. Biosimilars in the EU information guide for healthcare professionals [Internet]; 2019 [cited 2021 May 20]. Accessed June 8 2022https://www.ema.europa.eu/en/documents/leaflet/biosimilars‐eu‐information‐guide‐healthcare‐professionals_en.pdf.
4. EnglandNHS.What is a biosimilar medicine? [Internet]; 2019 May 30 [cited 2021 May 13]. Accessed June 8 2022. v2.pdf